Financial Performance - The company's revenue for Q3 2024 reached ¥894,697,144.70, representing a 5.12% increase year-over-year[2] - Net profit attributable to shareholders was ¥72,094,970.10, a significant increase of 285.65% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses was ¥55,336,809.23, up 225.04% year-over-year[2] - The basic earnings per share for the period was ¥0.161, reflecting an increase of 284.67% compared to the previous year[2] - Total operating revenue for Q3 2024 reached ¥2,305,366,010.42, an increase of 12.2% compared to ¥2,052,258,372.90 in the same period last year[15] - The net profit for the third quarter of 2024 was ¥111,848,795.94, a significant recovery from a net loss of ¥218,569,393.32 in the same period last year, marking a turnaround of over 151%[16] - The basic and diluted earnings per share for the third quarter were both ¥0.262, recovering from a loss of ¥0.393 per share in the same quarter last year[17] - The total profit for the quarter was ¥119,872,219.01, compared to a total loss of ¥255,944,149.78 in the same quarter last year[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,392,456,929.79, a decrease of 3.32% from the end of the previous year[2] - Total assets decreased to ¥9,392,456,929.79 from ¥9,715,376,558.83, a reduction of 3.3%[14] - Total liabilities decreased to ¥6,120,410,875.72 from ¥6,554,483,630.66, a decline of 6.6%[14] - The company’s total equity increased to ¥3,272,046,054.07 from ¥3,160,892,928.17, an increase of 3.5%[14] - The total equity attributable to shareholders increased by 4.05% to ¥3,026,654,077.52 compared to the end of the previous year[2] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥78,862,667.55, showing a 123.95% increase compared to the same period last year[8] - The cash flow from operating activities generated a net inflow of ¥78,862,667.55, a significant improvement from a net outflow of ¥329,247,654.83 in the previous year[18] - The company reported a net cash outflow from financing activities of ¥194,723,632.50, a significant increase of 648.64% compared to the previous year[8] - The company’s cash inflow from financing activities was ¥1,169,133,545.58, while cash outflow was ¥1,363,857,178.08, resulting in a net cash outflow of ¥194,723,632.50[19] - The company reported a net cash outflow from investing activities of ¥52,958,683.03, an improvement from a net outflow of ¥84,952,297.68 in the same period last year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,383[9] - Zhejiang Ruiyang Technology Co., Ltd. holds 15.33% of shares, totaling 68,780,733 shares[9] - Zhejiang Pudu Technology Co., Ltd. holds 11.55% of shares, totaling 51,821,600 shares[9] - The largest foreign shareholder, Island Honour Limited, holds 2.87% of shares, totaling 12,885,900 shares[9] - The total number of restricted shares at the beginning of the period was 262,500, with 106,575 shares added during the period[11] - The total number of unrestricted circulating shares held by the top ten shareholders is 68,780,733 shares[10] - The company has not disclosed any related party relationships among the top shareholders[10] - The company has a total of 0 preferred shareholders and no preferred shares held by the top ten shareholders[11] - The company has not reported any changes in the top ten shareholders due to securities lending or borrowing[10] - The company has a total of 369,075 restricted shares at the end of the period[11] Operating Costs and Expenses - Total operating costs decreased to ¥2,377,956,712.16 from ¥2,468,000,530.38, reflecting a reduction of 3.7%[15] - Research and development expenses decreased by 29.51% year-over-year, amounting to ¥311,207,645.74[7] - Research and development expenses for the quarter were ¥311,207,645.74, down 29.5% from ¥441,510,604.38 in the previous year[15] - The company's cash and cash equivalents decreased to ¥1,009,241,750.06 from ¥1,255,880,865.89, a decline of 19.6%[12] - Accounts receivable increased to ¥929,789,084.11, up 2.0% from ¥904,907,593.54 at the beginning of the period[12] - Inventory rose to ¥1,415,984,405.58, an increase of 3.0% compared to ¥1,373,751,754.01 at the start of the quarter[12] Investment Income - Investment income increased by 107.98% year-over-year, reaching ¥81,499,764.95 due to profit growth from joint ventures[7]

控股股东之一浙江睿洋科技有限公司保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：300203 证券简称：聚光科技 公告编号：2024-030 聚光科技（杭州）股份有限公司 关于控股股东部分股份被冻结的公告 技 持 有 本 公 司 的 5,260,000 股 股 份 进 行 司 法 拍 卖 ， 具 体 情 况 内 容 详 见 拍卖平台 "https://sf.taobao.com"公示的《网络竞价成功确认书》，上述司法拍卖尚未完成过户， 拍卖结果尚存在不确定性，本次拍卖不会导致本公司控制权发生变更。公司将持续关注上述 事项的进展，按照法律法规要求及时履行信息披露义务，并配合相关信息披露义务人履行披 露义务。 三、其他说明及风险提示 1、睿洋科技此次被司法冻结的658.40万股股票为睿洋科技因融资担保质押 给杭州工商信托股份有限公司的股票，详见本公司分别于2022年12月22日披露的 《关于控股股东办理质押回购业务、部分解除质押业务及部分股份被冻结的公 告》（公告编号2022- ...

Financial Performance - Net profit attributable to shareholders for the first three quarters of 2024 is expected to be between RMB 110 million and RMB 124 million, a significant improvement from a loss of RMB 176.2275 million in the same period last year[1] - Net profit attributable to shareholders for Q3 2024 is projected to be between RMB 67 million and RMB 77 million, compared to a loss of RMB 38.8346 million in Q3 2023[2] - Revenue for the reporting period reached approximately RMB 2.3 billion, a 12% increase year-over-year[4] - Operating cash flow improved significantly to approximately RMB 78 million[4] - Non-recurring gains and losses attributable to the company are estimated at around RMB 50 million, primarily from government subsidies[4] Cost and Expense Management - Gross margin improved due to optimized business and product structures, as well as enhanced contract quality[4] - Sales, management, and R&D expenses as a percentage of revenue and total amount decreased compared to the same period last year[4] Strategic Focus and Product Development - The company focused on developing high-end analytical instruments, scientific instruments, and related products in competitive fields such as clinical and life sciences, "dual-carbon" detection, and semiconductor precision testing[4]

证券代码：300203 证券简称：聚光科技 公告编号：2024-028 聚光科技（杭州）股份有限公司 关于控股股东办理质押回购业务及部分解除质押业务的公告 2、股东股份部分解除质押的基本情况 股东名称 是否为控股 股东或第一 大股东及其 一致行动人 本次解除质押股 份数量 占其所持 股份比例 占公司 总股本 比例 起始日 解除日期 质权人 普渡科技 是 8,508,600 16.42% 1.90% 2022-9-28 2024-9-27 杭州工商信 托股份有限 公司 普渡科技 是 3,200,000 6.18% 0.71% 2022-12-21 2024-9-27 杭州工商信 托股份有限 公司 | | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | | 持股比 | 本次质押、解 | 本次质押、解 | 占其所 | 占公司 | 情况 | | 情况 | | | 名称 | 持股数量 | 例 | 质押前质押股 | 质押后质押股 | 持股份 | 总股本 | ...

2、股东股份累计被质押及冻结的情况 二、其他相关说明 证券代码：300203 证券简称：聚光科技 公告编号：2024-027 聚光科技（杭州）股份有限公司 关于控股股东办理部分解除质押业务的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股东部分股份解除质押基本情况 聚光科技（杭州）股份有限公司（以下简称"本公司"）于近日接到本公司 控股股东之一浙江普渡科技有限公司（以下简称"普渡科技"）的通知，普渡 科技办理了部分解除质押业务，具体情况如下： | 1、股东股份部分解除质押的基本情况 | | --- | | 股东名称 | 是否为控股 股东或第一 大股东及其 | 本次解除质 押股份数量 | 占其所持 股份比例 | 占公司总 股本比例 | 起始日 | 解除日期 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 一致行动人 | | | | | | | | 普渡科技 | 是 | 3,110,000 | 6.00% | 0.69% | 2022-9-28 | 2024-9-20 | 杭州工商信 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-026 聚光科技（杭州）股份有限公司 关于公司及子公司获得政府补助的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、获得补助的基本情况 聚光科技（杭州）股份有限公司（以下简称"公司"、"聚光科技"）及子 公司自 2024 年 04 月 30 日至 2024 年 09 月 02 日累计收到各项政府补助资金共计 人民币 65,703,993.62 元，其中增值税即征即退资金为人民币 32,957,309.01 元，与公司日常经营活动密切相关，具有可持续性；其他政府补助资金为人民币 32,746,684.61 元。现将具体情况分别列示如下： （一）补助的类型 公司取得的、用于购建或以其他方式形成长期资产的政府补助划分为与资产 相关的政府补助。与资产相关的政府补助，确认为递延收益，并在相关资产使用 寿命内按照合理、系统的方法分期计入损益。但是，按照名义金额计量的政府补 助，直接计入当期损益。相关资产在使用寿命结束前被出售、转让、报废或发生 毁损的，将尚未分配的相关递延收益余额转入资产处置当期的损益。除 ...

关于控股股东部分股份被司法冻结的公告 控股股东之一浙江睿洋科技有限公司保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 证券代码：300203 证券简称：聚光科技 公告编号：2024-025 聚光科技（杭州）股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 聚光科技（杭州）股份有限公司（以下简称"本公司"）于近日接到本公司 控股股东之一浙江睿洋科技有限公司（以下简称"睿洋科技"）的通知，获悉 睿洋科技所持有本公司的部分股份被司法冻结，具体情况如下： 2、本次控股股东睿洋科技所持公司部分股份被司法再冻结，不会导致本公 司控制权发生变更，不会对公司的正常生产经营活动、公司治理等产生重大影响。 睿洋科技不存在非经营性资金占用、违规担保等侵害上市公司利益的情形。 | 股东名 | 是否为控股股东 或第一大股东及 | 本次冻结股 | 占其所持 | 占公司总 | 是否为 | 起始 | 到期 | 冻结申请人 | 原因 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | -- ...

证券代码：300203 证券简称：聚光科技 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |---------------------|---------------------------------------|----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | 编号： 2024-006 | | 投资者关系活 动类别 | □特定对象调研 □媒体采访 □业绩说明会 | □分析师会议 | | | | □新闻发布会 □路演活动 | | | | | □现场参观 | □一对一沟通 | | | | ■其他（电话会议调研） | | | | 参与单位名称 | | | 中信建投证券 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has turned from loss to profit, focusing on cost reduction and efficiency improvements in high-end scientific instruments [1][4] - In H1 2024, the company achieved revenue of 1.411 billion yuan, a year-on-year increase of 17.44%, and a net profit attributable to shareholders of 46 million yuan, a year-on-year increase of 133.16% [3][4] - The company signed new contracts worth 1.667 billion yuan in H1 2024, representing a year-on-year growth of 11.13% [3] Financial Performance - The company reported a Q2 revenue of 871 million yuan, a year-on-year increase of 27.75%, and a net profit of 71 million yuan, a year-on-year increase of 241.47% and a quarter-on-quarter increase of 380.27% [3] - The overall gross margin for H1 2024 was 44.44%, up 3.99 percentage points year-on-year [3] - The company reduced its expense ratio to 50.51%, down 13.57 percentage points year-on-year, with significant reductions in sales, management, financial, and R&D expense ratios [3][4] Business Segments - Revenue from instrument-related business, operational testing, and environmental equipment and engineering was 968 million yuan, 241 million yuan, and 139 million yuan respectively, with year-on-year growth rates of 15.35%, 37.33%, and 14.89% [3] - The company has made progress in high-end scientific instruments, particularly in mass spectrometry, chromatography, and spectroscopy, with successful product launches in life sciences and semiconductor fields [4] Future Outlook - The company expects revenues of 3.412 billion yuan, 3.911 billion yuan, and 4.515 billion yuan for 2024, 2025, and 2026 respectively, with growth rates of 7.2%, 14.6%, and 15.4% [4][5] - The net profit forecast for the same period is 113 million yuan, 234 million yuan, and 390 million yuan [4][5]

Investment Rating - The report maintains a "Buy" rating for the company [1][3] Core Insights - The company reported a revenue of 1.41 billion RMB for the first half of 2024, representing a year-over-year increase of 17.44%. The net profit attributable to shareholders was 46 million RMB, a significant improvement from a loss of 137 million RMB in the same period last year [1] - The operating cash flow showed a notable improvement, with a net cash flow of -78 million RMB compared to -317 million RMB in the previous year. In Q2, the operating cash flow turned positive at 55 million RMB, up from -167 million RMB year-over-year [2] - The company has optimized its cost structure, with a decrease in sales expense ratio to 19.6% (down 2.48 percentage points), management expense ratio to 9.6% (down 0.8 percentage points), and R&D expense ratio to 15.472% (down 9.2 percentage points) [2] - The gross margin improved to 44.44%, an increase of 3.99 percentage points, with high-margin business segments showing significant growth [2] Financial Forecasts - The expected EPS for 2024, 2025, and 2026 is projected to be 0.40 RMB, 0.75 RMB, and 1.00 RMB respectively. The current stock price corresponds to a PE ratio of 27, 14, and 11 for the respective years [3] - The company is expected to see a revenue growth rate of 9.56% in 2024, followed by 10.94% in 2025 and 12.18% in 2026 [6]